Pharma Manufacturing

The Pharma Innovation Awards are a celebration of technologies contributing to advancements in quality, efficiency and risk reduction. Did your company launch a product during the past year that's a game-changer for pharma manufacturers? Submit using our easy online form; deadline is August 9. https://lnkd.in/gnMKhpkE #pharmainnovationawards #pharmamanufacturing #pharmanews

Check out this week's Editors' (re)View. Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of July 14. This week, Andrea Corona discusses the future of weight loss drugs as drug makers are shifting to oral formulations for their treatments. Pfizer, Genentech, Novo Nordisk #Pfizer #Genentech #NovoNordisk #Pharmanews #pharmamanufacturing #editorsreview #weightloss #weightlossdrugs #oralformulations #injections https://lnkd.in/gAkM-Syp

Catch up on last week's news from the pharma industry with a new episode of Off Script: A Pharma Manufacturing Podcast, the good, the bad, the ugly. Listen with the link below or find us on your favorite podcast app. Up this week: The good — Pfizer advances once-daily obesity pill  The bad — FDA rejects Novo Nordisk once-weekly insulin  The ugly — Federal Trade Commission releases long-awaited report on PBMs #Pfizer #FDA #FTC #Offscript #NovoNordisk #Pharmamanufacturing #Pharmanews #podcast #pharmapodcast #thegoodthebadtheugly #insulin #FDArejection #PBMs #obesitypill https://lnkd.in/gnwQiGtd

Check out this week's Editors' (re)View. Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of July 8. This week we saw two drugmakers betting on second chances: Roche is making a comeback with its neovascular or 'wet' age-related macular degeneration (nAMD) treatment while Elevar Therapeutics is gearing up to resubmit its liver cancer drug. This week also covers the FTC release of a long-awaited report on the prescription drug middleman industry. Federal Trade Commission #Roche #Elevar #nAMD #livercancerdrug #FTC #FederalTradeCommission #pharmamanufacturing #pharmanews #editorsreview https://lnkd.in/e3HNCvHx

I will be speaking on IndustryWeek's Production Pulse panel today. Join us as we discuss the reshoring movement across manufacturing.

Catch up on last week's news from the pharma industry with a new episode of Off Script: A Pharma Manufacturing Podcast, the good, the bad, the ugly. Listen with the link below or find us on your favorite podcast app. Up this week: The good — FDA grants Eli Lilly and Company Alzheimer’s drug full approval  The bad — FDA rejects Rocket gene therapy  The ugly — Eisai, BMS end ADC partnership Eisai US, Bristol Myers Squibb #FDA #EliLilly #Alzheimersdrug #Rocket #Eisai #BMS #BristolMyersSquibb #pharmamanufacturing #pharmanews #offscript #podcast #thegoodthebadtheugly https://lnkd.in/gJE9h9ya

By integrating a Quality by Design (QbD) approach, developers can design robust packaging from the outset,  drastically reducing development time and costs. Understanding how moisture affects a product is key, allowing developers to use industry-accepted and validated models to predict and address potential stability issues early in the design phase, thereby reducing the need for prolonged probe stability testing and potential reformulations or packaging redesign. To understand more about the issues at hand, senior editor Andrea Corona recently spoke with Adrian Possumato, president and Chris Gilmor, director of sales, at Sanner of America in this episode of Off Script:  A Pharma Manufacturing Podcast. Listen with the link below or on your favorite streaming service. https://lnkd.in/gAjvV8vJ Sanner Of America Inc #SannerofAmerica #qualitybydesign #oraldosepackaging #oraldose #offscript #pharmamanufacturing

It's that time again for Editors' (re)View. Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of July 1. This week covers Moderna's announcement that it had received a $176 million project award and the FDA approval of Eli lilly's donanemab, branded as Kisunla, a once-monthly IV infusion therapy for early symptomatic Alzheimer's disease. #Pharmamanufacturing #pharmanews #editorsreview #moderna #fda #elililly #alzheimerstreatment #alzheimers https://lnkd.in/g7TyBEa4

Catch up on last week's news from the pharma industry with a new episode of Off Script: A Pharma Manufacturing Podcast, the good, the bad, the ugly. Listen with the link below or find us on your favorite podcast app. Up this week: The good — Verona Pharma wins FDA nod for COPD  The bad — FDA issues CRL to Merck-Daiichi lung cancer ADC  The ugly — Glenmark Pharmaceuticals recalls 114 batches of potassium chloride capsules Merck, Daiichi Sankyo US #VeronaPharma #FDA #COPD #CRL #Merck #DaiichiSankyo #GlenmarkPharma #potassiumchloride #pharmamanufacturing #pharmanews #offscript #thegoodthebadtheugly #podcast https://lnkd.in/gshSjSzr

Editors' (re)View is back. Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of June 22. This week covers the FDA's statement that interchangeability studies may soon be obsolete and the rough week pharma CDMOs had. #pharmamanufacturing #pharmanews #editorsreview #fda #interchangeabilitystudies #pharmacdmo #AbbVie #DaiichiSankyo #Merck https://lnkd.in/gkPYGDgR